Schechter Adam H — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Schechter Adam H has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $8.45M.

Profile

Adam H. Schechter is the President and CEO of DaVita Inc., a leading provider of dialysis services in the United States. He has held various leadership roles within the healthcare sector and is known for his contributions to improving patient care and operational efficiency.

Board memberships

• DaVita Inc.
• LabCorp Holdings Inc.

Awards & honors

• Leadership in expanding dialysis services
• Operational improvements at DaVita
• Strategic initiatives in healthcare management

Recent Transactions

Companies — Last 90 Days

• DAVITA INC. (DVA) — 1 filings, last 2026-05-18
• LABCORP HOLDINGS INC. (LH) — 1 filings, last 2026-05-13

Frequently Asked Questions

Who is Schechter Adam H?

Adam H. Schechter is the President and CEO of DaVita Inc., a leading provider of dialysis services in the United States. He has held various leadership roles within the healthcare sector and is known for his contributions to improving patient care and operational efficiency.…

How many SEC Form 4 filings has Schechter Adam H submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Schechter Adam H been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($8.45M) across all tracked filings.

Where can I see all of Schechter Adam H's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week